UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025098 |
|---|---|
| Receipt number | R000028862 |
| Scientific Title | Evaluation of the effects of the fermented milk drink-1 containing Lactobacillus casei NY1301 |
| Date of disclosure of the study information | 2016/12/26 |
| Last modified on | 2017/07/05 13:42:43 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Evaluation of the effects of the fermented milk drink-1 containing Lactobacillus casei NY1301
Acronym
Evaluation of the effects of the fermented milk drink-1
Scientific Title
Evaluation of the effects of the fermented milk drink-1 containing Lactobacillus casei NY1301
Scientific Title:Acronym
Evaluation of the effects of the fermented milk drink-1
Region
| Japan |
Condition
Condition
Subjects who have a tendency to be constipated
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To evaluate the effects of the fermented milk drink containing Lactobacillus casei NY1301 on bowel movement of subjects who have a tendency to be constipated
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Defecation frequency, fecal amount
Key secondary outcomes
Fecal shape, fecal color, feelings after defecation, analysis of intestinal microflora
Base
Study type
Interventional
Study design
Basic design
Cross-over
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
YES
Dynamic allocation
NO
Institution consideration
Institution is considered as a block.
Blocking
NO
Concealment
Central registration
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Intake of the fermented milk drink for 2 weeks
Interventions/Control_2
Intake of the placebo drink for 2 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 70 | years-old | > |
Gender
Male and Female
Key inclusion criteria
(1)Males and females from 20 to 70 years-old
(2)Subjects who have a tendency to be constipated defecate two to five times a week
(3)Subjects undergoing none of medical treatments
(4)Subjects eat regularly
Key exclusion criteria
(1)Subjects with a serious disease
(2)Subjects have a medical history or a surgical history of digestive diseases
(3)Subjects allergic to a specific drug or food
(4)Subjects work alternative or midnight shifts
(5)Subjects never be able to stop intaking foods or drinks which improve constipation during study,such as foods containing lactic acid bacteria,bifidobacteria,natto bacteria,oligosaccharides,dietary fibers and/or other health foods including food for specified health use
(6)Subjects taking any kinds of drugs affect this study(constipation drugs,intestinal drugs,etc.)
(7)Subjects drink alcohol over 500mL in terms of beer per day
(8)Subjects smoke over 20 cigarettes per day
(9)Subjects drawn blood over 200mL last 1 month,or over 400mL last 3 months
(10)Subjects allergic to samples in this study
(11)Pregnants,lactating women or who is going to be pregnant
(12)Subjects who have participated in the other clinical studies
(13)Subjects judged as unsuitable for the study by the principal investigator for other reasons
Target sample size
70
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hiroshi Moriyama |
Organization
Kanazawabunko Hospital
Division name
Vice president
Zip code
Address
2-6-22,Kamariyahigashi,Kanazawa-ku, Yokohama city,Kanagawa,Japan
TEL
045-785-3311
nagashima@kanabun-hp.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Soichi Yoneda |
Organization
QOL RD Co.,Ltd.
Division name
CRO Department Food Division
Zip code
Address
2-14-1,Nihonbashi,Chuo-ku,Tokyo,
TEL
03-6386-8809
Homepage URL
s-yoneda@qol-rd.co.jp
Sponsor or person
Institute
QOL RD Co.,Ltd.
Institute
Department
Personal name
Funding Source
Organization
Nissin York Co.,Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
金沢文庫病院（神奈川県）、上尾甦生病院（埼玉県）、白岡中央総合病院（埼玉県）、さがみリハビリテーション病院（神奈川県）、メディカルトピア草加病院（埼玉県）、桜ヶ丘中央病院（神奈川県）、横浜なみきリハビリテーション病院（神奈川県）、浅草病院（東京都）、カイユウ診療所（東京都）、武蔵境クリニック（東京都）、日本橋ハートクリニック（東京都）、八木病院（東京都）、戸田中央総合病院（埼玉県）
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 12 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2016 | Year | 10 | Month | 27 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 12 | Month | 26 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2016 | Year | 12 | Month | 01 | Day |
Last modified on
| 2017 | Year | 07 | Month | 05 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028862
